Viridian Therapeutics, Inc. (VRDN)
13.34
-0.14
(-1.04%)
USD |
NASDAQ |
May 01, 10:04
Viridian Therapeutics Market Cap : 1.363B for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 179.06B |
| Marker Therapeutics, Inc. | 24.68M |
| Boston Scientific Corp. | 85.71B |
| Plus Therapeutics, Inc. | 40.49M |
| Nutriband, Inc. | 47.06M |
Market Cap Related Metrics
| PS Ratio | 15.96 |
| PEG Ratio | -4.134 |
| Price to Book Value | 2.310 |
| Price | 13.34 |
| Earnings Yield | -28.53% |
| PEGY Ratio | -4.134 |